Business Context and Reporting Period
Company: Mineralys Therapeutics, Inc. (MLYS)
Filing Type: Form 8-K (Current Report)
Date of Report: June 3, 2026
Event: Entry into an underwriting agreement for a public offering of common stock.
Key Financial Metrics
This filing reports on a capital raise event rather than operational financial performance. Key metrics related to the transaction include:
- Shares Issued: 5,660,378 shares of Common Stock.
- Public Offering Price: $26.50 per share.
- Price to Company: $25.3075 per share (after underwriting discounts).
- Expected Net Proceeds: Approximately $142.5 million (after deducting underwriting discounts, commissions, and estimated offering expenses).
- Underwriters: BofA Securities, Inc., Goldman Sachs & Co. LLC, and Evercore Group L.L.C.
Note: The filing does not provide historical revenue, profit, cash flow, margins, debt, or liquidity figures.
Material Changes
The primary material change is the dilution of existing shareholders due to the issuance of 5,660,378 new shares and the anticipated increase in the company's cash position by approximately $142.5 million upon closing.
Guidance, Outlook, and Risks
- Closing Date: Expected on June 4, 2026, subject to customary closing conditions.
- Forward-Looking Statements: The company cautions that actual results may differ from expectations due to market conditions and the satisfaction of closing conditions.
- Risks: The offering is contingent on customary conditions. The company references risks inherent in its business as described in other SEC filings.
- Legal: The Underwriting Agreement includes customary representations, warranties, indemnification obligations, and termination provisions.
Investor Verification Checklist
- Verify the final closing of the offering on or after June 4, 2026.
- Confirm the actual net proceeds received after all expenses are finalized.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) for specific termination rights and conditions.
- Check subsequent filings for the updated share count and capitalization table.
- Review the company's most recent 10-K or 10-Q for baseline liquidity and cash burn rates to assess the runway provided by the $142.5 million raise.